Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.587,62
1,11%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Minerva Neurosciences Inc (NERV) Minerva Neurosciences Inc (NERV) Notizie

Minerva Neurosciences Inc

NERV
2,37
0,02 (0,85%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202413:30GLOBEMinerva Neurosciences Reports First Quarter 2024 Financial..
27/2/202414:04EDGAR2Form 8-K - Current report
27/2/202414:00GLOBEMinerva Neurosciences Receives Complete Response Letter from..
22/2/202413:00GLOBEMinerva Neurosciences Reports Fourth Quarter and Fiscal Year..
22/2/202412:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/11/202313:30GLOBEMinerva Neurosciences Reports 2023 Third Quarter Financial..
07/11/202313:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/10/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202314:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202314:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202322:05EDGAR2Form 8-K - Current report
15/8/202315:28EDGAR2Form ARS - Annual Report to Security Holders
15/8/202315:26EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/8/202315:25EDGAR2Form DEF 14A - Other definitive proxy statements
09/8/202323:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/8/202314:07EDGAR2Form S-3 - Registration statement under Securities Act of..
01/8/202313:30GLOBEMinerva Neurosciences Reports 2023 Second Quarter Financial..
01/8/202313:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/7/202322:18EDGAR2Form SC 13D - General statement of acquisition of beneficial..
28/6/202314:37EDGAR2Form 8-K - Current report
28/6/202314:30GLOBEMinerva Neurosciences Announces $20 Million in Private..
15/5/202313:30GLOBEMinerva Neurosciences Reports 2023 First Quarter Financial..
10/5/202314:00GLOBEMinerva Neurosciences Announces Update on its New Drug..
08/5/202314:30GLOBEMinerva Neurosciences to Report First Quarter 2023 Financial..
Apertura: 2,39 Min: 2,36 Max: 2,41
Chiusura: 2,35

La tua Cronologia

NASDAQ
NERV
Minerva Neurosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network